Phase II trial of chronic daily VP-16 administration in unresectable hepatocellular carcinoma (HCC)

Rafal Wierzbicki(King Faisal Specialist Hospital & Research Centre), Adnan El Yazigi, Abdel‐Wahab A. Abdel‐Warith(King Saud University), Mohammed Al Fadda, Tarek Amin, Ingvar Kagevi, Munjid Hasballah Abdulkareem, Ali A. Ayoub, Adnan Ezzat(King Faisal Specialist Hospital & Research Centre), Jens O. Sieck
Annals of Oncology
May 1, 1994
Cited by 14


Related Papers